27-hydroxycholesterol has been researched along with staurosporine in 1 studies
| Studies (27-hydroxycholesterol) | Trials (27-hydroxycholesterol) | Recent Studies (post-2010) (27-hydroxycholesterol) | Studies (staurosporine) | Trials (staurosporine) | Recent Studies (post-2010) (staurosporine) |
|---|---|---|---|---|---|
| 345 | 11 | 214 | 6,272 | 58 | 976 |
| Protein | Taxonomy | 27-hydroxycholesterol (IC50) | staurosporine (IC50) |
|---|---|---|---|
| Chain A, Ribosomal protein S6 kinase alpha-1 | Homo sapiens (human) | 0.0003 | |
| Chain X, Tyrosine-protein kinase Lyn | Homo sapiens (human) | 0.0013 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Emanuelsson, I; Norlin, M | 1 |
1 other study(ies) available for 27-hydroxycholesterol and staurosporine
| Article | Year |
|---|---|
Protective effects of 27- and 24-hydroxycholesterol against staurosporine-induced cell death in undifferentiated neuroblastoma SH-SY5Y cells.
Topics: Apoptosis; Caspase 3; Caspase 7; Cell Differentiation; Cell Line, Tumor; Cell Survival; Drug Synergism; Humans; Hydroxycholesterols; L-Lactate Dehydrogenase; Neuroblastoma; Neuroprotective Agents; Staurosporine | 2012 |